A Study to Compare the Efficacy and Safety of Levofloxacin in the Treatment of Children With Community-acquired Pneumonia in the Hospital or Outpatient Setting

PHASE3CompletedINTERVENTIONAL
Enrollment

691

Participants

Timeline

Start Date

August 31, 2002

Study Completion Date

June 30, 2004

Conditions
Pneumonia
Interventions
DRUG

Levofloxacin

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00034736 - A Study to Compare the Efficacy and Safety of Levofloxacin in the Treatment of Children With Community-acquired Pneumonia in the Hospital or Outpatient Setting | Biotech Hunter | Biotech Hunter